Filed: 2/14/2024ACC: 0001012975-24-000083
📋 What this filing means
ARCH VENTURE MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 7 equity positions with a total reported market value of $163.51M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
7
Positions
$163.51M
Total AUM (reported)
29.54M
Total Shares
Allocation by class
COM$163.51M100.0%
Portfolio Concentration
Top 3$144.29M88.2%
4–10$19.22M11.8%
Top 3 weight
88.2%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 29.54M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
29.54M
shares
% of voting shares100.0%
Investment Discretion (by position count)
Sole7
Shared0
Other0
Dominant voting typeNone · 100.0% of voting shares
Institutional Holdings7
Rows:
REVOLUTION MEDICINES, INC.
SOLEShares3.23M
TypeSH
Market value$92.74M
56.72%
Sole
0.00
Shared
0.00
None
3.23M
VERVE THERAPEUTICS, INC.
SOLEShares2.01M
TypeSH
Market value$28.00M
17.13%
Sole
0.00
Shared
0.00
None
2.01M
ERASCA, INC.
SOLEShares11.06M
TypeSH
Market value$23.55M
14.40%
Sole
0.00
Shared
0.00
None
11.06M
DENALI THERAPEUTICS, INC.
SOLEShares381.25K
TypeSH
Market value$8.18M
5.00%
Sole
0.00
Shared
0.00
None
381.25K
GOSSAMER BIO, INC.
SOLEShares8.06M
TypeSH
Market value$7.35M
4.50%
Sole
0.00
Shared
0.00
None
8.06M
UNITY BIOTECHNOLOGY, INC.
SOLEShares1M
TypeSH
Market value$1.94M
1.19%
Sole
0.00
Shared
0.00
None
1M
SINGULAR GENOMICS SYSTEMS, INC.
SOLEShares3.80M
TypeSH
Market value$1.75M
1.07%
Sole
0.00
Shared
0.00
None
3.80M
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
REVOLUTION MEDICINES, INC.SOLE | COM | 3.23M | SH | $92.74M 56.72% | 0.00 | 0.00 | 3.23M |
VERVE THERAPEUTICS, INC.SOLE | COM | 2.01M | SH | $28.00M 17.13% | 0.00 | 0.00 | 2.01M |
ERASCA, INC.SOLE | COM | 11.06M | SH | $23.55M 14.40% | 0.00 | 0.00 | 11.06M |
DENALI THERAPEUTICS, INC.SOLE | COM | 381.25K | SH | $8.18M 5.00% | 0.00 | 0.00 | 381.25K |
GOSSAMER BIO, INC.SOLE | COM | 8.06M | SH | $7.35M 4.50% | 0.00 | 0.00 | 8.06M |
UNITY BIOTECHNOLOGY, INC.SOLE | COM | 1M | SH | $1.94M 1.19% | 0.00 | 0.00 | 1M |
SINGULAR GENOMICS SYSTEMS, INC.SOLE | COM | 3.80M | SH | $1.75M 1.07% | 0.00 | 0.00 | 3.80M |